News

Mauna Kea Technologies reports fourth quarter and full year 2019 sales

29 January 2020

 Full Year 2019 total sales up 10% 
Sales to clinical customers up 27%, driven by 89% growth in consumables sales related to pay-per-use program 

Fourth Quarter total sales down 20% 
Fourth quarter sales to clinical customers down 18%, driven by 29% increase in consumables sales which partially offset expected year-over-year decline in US capital sales 

Latest News

Publication of the 2025 Annual Financial Report 

Publication of the 2025 Annual Financial Report 

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

No results found.